| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF20 ZNF836 ZFAT ZEB1 ZBTB39 ZNF354A ZNF670 ZNF684 ZNF780B ZNF518B ZNF841 SUZ12 ZNF705B BCOR ZEB2 ZNF705D THAP11 | 1.38e-06 | 1459 | 62 | 17 | GO:0000977 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF20 ZNF836 ZFAT ZEB1 ZBTB39 ZNF354A ZNF670 ZNF684 ZNF780B ZNF518B ZNF841 ZNF705B ZEB2 ZNF705D THAP11 | 2.01e-05 | 1412 | 62 | 15 | GO:0000981 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF836 ZFAT ZEB1 ZBTB39 ZNF354A ZNF670 ZNF780B ZNF841 SUZ12 ZEB2 ELL THAP11 | 4.66e-04 | 1271 | 62 | 12 | GO:0000987 |
| GeneOntologyMolecularFunction | gamma-catenin binding | 6.14e-04 | 12 | 62 | 2 | GO:0045295 | |
| GeneOntologyMolecularFunction | interleukin-1 binding | 6.14e-04 | 12 | 62 | 2 | GO:0019966 | |
| Domain | ZINC_FINGER_C2H2_2 | ZNF20 ZNF836 ZFAT ZEB1 ZBTB39 ZNF354A ZNF670 ZNF684 ZNF592 ZNF618 ZNF780B ZNF518B ZNF841 ZFPM1 SUZ12 ZNF705B ZNF285 ZEB2 ZNF705D ZNF541 | 1.57e-13 | 775 | 60 | 20 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF20 ZNF836 ZFAT ZEB1 ZBTB39 ZNF354A ZNF670 ZNF684 ZNF592 ZNF618 ZNF780B ZNF518B ZNF841 ZFPM1 SUZ12 ZNF705B ZNF285 ZEB2 ZNF705D ZNF541 | 1.65e-13 | 777 | 60 | 20 | PS00028 |
| Domain | Znf_C2H2-like | ZNF20 ZNF836 ZFAT ZEB1 ZBTB39 ZNF354A ZNF670 ZNF684 ZNF592 ZNF618 ZNF780B ZNF518B ZNF841 ZFPM1 SUZ12 ZNF705B ZNF285 ZEB2 ZNF705D ZNF541 | 2.59e-13 | 796 | 60 | 20 | IPR015880 |
| Domain | ZnF_C2H2 | ZNF20 ZNF836 ZFAT ZEB1 ZBTB39 ZNF354A ZNF670 ZNF684 ZNF592 ZNF618 ZNF780B ZNF518B ZNF841 ZFPM1 SUZ12 ZNF705B ZNF285 ZEB2 ZNF705D ZNF541 | 3.42e-13 | 808 | 60 | 20 | SM00355 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF20 ZNF836 ZFAT ZEB1 ZBTB39 ZNF354A ZNF670 ZNF684 ZNF618 ZNF780B ZNF518B ZNF841 ZFPM1 ZNF705B ZNF285 ZEB2 ZNF705D ZNF541 | 3.15e-12 | 694 | 60 | 18 | IPR013087 |
| Domain | Znf_C2H2 | ZNF20 ZNF836 ZFAT ZEB1 ZBTB39 ZNF354A ZNF670 ZNF684 ZNF592 ZNF618 ZNF780B ZNF518B ZNF841 ZFPM1 ZNF705B ZNF285 ZEB2 ZNF705D ZNF541 | 3.55e-12 | 805 | 60 | 19 | IPR007087 |
| Domain | - | ZNF20 ZNF836 ZFAT ZEB1 ZBTB39 ZNF354A ZNF670 ZNF684 ZNF618 ZNF780B ZNF841 ZFPM1 ZNF705B ZNF285 ZEB2 ZNF705D ZNF541 | 2.50e-11 | 679 | 60 | 17 | 3.30.160.60 |
| Domain | zf-C2H2 | ZNF20 ZNF836 ZFAT ZBTB39 ZNF354A ZNF670 ZNF684 ZNF592 ZNF780B ZNF841 ZFPM1 ZNF705B ZNF285 ZNF705D ZNF541 | 3.37e-09 | 693 | 60 | 15 | PF00096 |
| Domain | KRAB | ZNF20 ZNF836 ZNF354A ZNF670 ZNF684 ZNF780B ZNF705B ZNF285 ZNF705D | 1.97e-06 | 358 | 60 | 9 | PS50805 |
| Domain | KRAB | ZNF20 ZNF836 ZNF354A ZNF670 ZNF684 ZNF780B ZNF705B ZNF285 ZNF705D | 1.97e-06 | 358 | 60 | 9 | PF01352 |
| Domain | KRAB | ZNF20 ZNF836 ZNF354A ZNF670 ZNF684 ZNF780B ZNF705B ZNF285 ZNF705D | 2.53e-06 | 369 | 60 | 9 | SM00349 |
| Domain | KRAB | ZNF20 ZNF836 ZNF354A ZNF670 ZNF684 ZNF780B ZNF705B ZNF285 ZNF705D | 2.59e-06 | 370 | 60 | 9 | IPR001909 |
| Domain | zf-C2H2_6 | 6.99e-06 | 314 | 60 | 8 | PF13912 | |
| Domain | Di19_Zn_binding_dom | 2.11e-04 | 7 | 60 | 2 | IPR008598 | |
| Domain | zf-Di19 | 2.11e-04 | 7 | 60 | 2 | PF05605 | |
| Domain | zf-C2H2_11 | 3.60e-04 | 9 | 60 | 2 | PF16622 | |
| Domain | MAM_1 | 1.18e-03 | 16 | 60 | 2 | PS00740 | |
| Domain | MAM | 1.34e-03 | 17 | 60 | 2 | SM00137 | |
| Domain | MAM | 1.50e-03 | 18 | 60 | 2 | PF00629 | |
| Domain | MAM_dom | 1.50e-03 | 18 | 60 | 2 | IPR000998 | |
| Domain | MAM_2 | 1.50e-03 | 18 | 60 | 2 | PS50060 | |
| Domain | ConA-like_dom | 5.37e-03 | 219 | 60 | 4 | IPR013320 | |
| Domain | PTPc | 5.96e-03 | 36 | 60 | 2 | SM00194 | |
| Domain | TYR_PHOSPHATASE_PTP | 6.97e-03 | 39 | 60 | 2 | PS50055 | |
| Pubmed | 5.66e-09 | 3 | 63 | 3 | 29052277 | ||
| Pubmed | ZEBs: Novel Players in Immune Cell Development and Function. | 3.23e-06 | 2 | 63 | 2 | 30956067 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 28416756 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 12609600 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 24306957 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 20375168 | ||
| Pubmed | Prognostic Significance of Zinc Finger E-Box-Binding Homeobox Family in Glioblastoma. | 3.23e-06 | 2 | 63 | 2 | 29476046 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 22213144 | ||
| Pubmed | Functional conservation of zinc-finger homeodomain gene zfh1/SIP1 in Drosophila heart development. | 3.23e-06 | 2 | 63 | 2 | 16957952 | |
| Pubmed | The mesodermal and myogenic specification of hESCs depend on ZEB1 and are inhibited by ZEB2. | 3.23e-06 | 2 | 63 | 2 | 37819755 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 22892238 | ||
| Pubmed | The Zeb proteins δEF1 and Sip1 may have distinct functions in lens cells following cataract surgery. | 3.23e-06 | 2 | 63 | 2 | 25082886 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 20025777 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 20424117 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 21747944 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 37948583 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 28133913 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 34550965 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 7.77e-06 | 398 | 63 | 7 | 35016035 | |
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 21890822 | ||
| Pubmed | TCF4 promotes colorectal cancer drug resistance and stemness via regulating ZEB1/ZEB2 expression. | 9.68e-06 | 3 | 63 | 2 | 31933004 | |
| Pubmed | Down-regulation of miR-144 promotes thyroid cancer cell invasion by targeting ZEB1 and ZEB2. | 9.68e-06 | 3 | 63 | 2 | 24968735 | |
| Pubmed | Expression of miR-9 and miR-200c, ZEB1, ZEB2 and E-cadherin in Non-Small Cell Lung Cancers in Iran. | 9.68e-06 | 3 | 63 | 2 | 31244281 | |
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 34226299 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 26823172 | ||
| Pubmed | A miRNA signature associated with human metastatic medullary thyroid carcinoma. | 9.68e-06 | 3 | 63 | 2 | 24127332 | |
| Pubmed | p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. | 9.68e-06 | 3 | 63 | 2 | 21518799 | |
| Pubmed | miR-139-5p suppresses cancer cell migration and invasion through targeting ZEB1 and ZEB2 in GBM. | 9.68e-06 | 3 | 63 | 2 | 25833697 | |
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 26022123 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 21411626 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 24165969 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 36940483 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 23412770 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 17615296 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 26556542 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 18376396 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 18411277 | ||
| Pubmed | BMP4 signaling mediates Zeb family in developing mouse tooth. | 9.68e-06 | 3 | 63 | 2 | 22350174 | |
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 29302045 | ||
| Pubmed | 1.12e-05 | 24 | 63 | 3 | 19616115 | ||
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 18289379 | ||
| Pubmed | Fra-1/AP-1 induces EMT in mammary epithelial cells by modulating Zeb1/2 and TGFβ expression. | 1.93e-05 | 4 | 63 | 2 | 25301070 | |
| Pubmed | miR-200b regulates cell migration via Zeb family during mouse palate development. | 1.93e-05 | 4 | 63 | 2 | 22261924 | |
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 17360662 | ||
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 23381389 | ||
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 28247944 | ||
| Pubmed | Activation of Src and transformation by an RPTPα splice mutant found in human tumours. | 1.93e-05 | 4 | 63 | 2 | 21725282 | |
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 16598713 | ||
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 31679088 | ||
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 29200203 | ||
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 21079000 | ||
| Pubmed | The MicroRNA 29 Family Promotes Type II Cell Differentiation in Developing Lung. | 1.93e-05 | 4 | 63 | 2 | 27215389 | |
| Pubmed | 1.99e-05 | 181 | 63 | 5 | 37372979 | ||
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 2.15e-05 | 184 | 63 | 5 | 32908313 | |
| Pubmed | 3.22e-05 | 5 | 63 | 2 | 18829540 | ||
| Pubmed | 3.22e-05 | 5 | 63 | 2 | 9724649 | ||
| Pubmed | 3.22e-05 | 5 | 63 | 2 | 12743039 | ||
| Pubmed | Opposing functions of ZEB proteins in the regulation of the TGFbeta/BMP signaling pathway. | 3.22e-05 | 5 | 63 | 2 | 12743038 | |
| Pubmed | A developmentally regulated inducer of EMT, LBX1, contributes to breast cancer progression. | 3.22e-05 | 5 | 63 | 2 | 19651985 | |
| Pubmed | ZEB1, ZEB2, and the miR-200 family form a counterregulatory network to regulate CD8+ T cell fates. | 3.22e-05 | 5 | 63 | 2 | 29449309 | |
| Pubmed | 4.82e-05 | 6 | 63 | 2 | 12161443 | ||
| Pubmed | 4.82e-05 | 6 | 63 | 2 | 22685266 | ||
| Pubmed | 8.98e-05 | 8 | 63 | 2 | 16061479 | ||
| Pubmed | A Zeb2-miR-200c loop controls midbrain dopaminergic neuron neurogenesis and migration. | 8.98e-05 | 8 | 63 | 2 | 30271956 | |
| Pubmed | 8.98e-05 | 8 | 63 | 2 | 12714599 | ||
| Pubmed | 8.98e-05 | 8 | 63 | 2 | 25460509 | ||
| Pubmed | 8.98e-05 | 8 | 63 | 2 | 7499252 | ||
| Pubmed | 8.98e-05 | 8 | 63 | 2 | 31511647 | ||
| Pubmed | 1.11e-04 | 418 | 63 | 6 | 34709266 | ||
| Pubmed | 1.15e-04 | 9 | 63 | 2 | 24769727 | ||
| Pubmed | Maternal diabetes induces senescence and neural tube defects sensitive to the senomorphic rapamycin. | 1.44e-04 | 10 | 63 | 2 | 34193422 | |
| Pubmed | 1.44e-04 | 10 | 63 | 2 | 23119100 | ||
| Pubmed | 2.49e-04 | 13 | 63 | 2 | 29119051 | ||
| Pubmed | 2.62e-04 | 313 | 63 | 5 | 20800603 | ||
| Pubmed | 2.70e-04 | 493 | 63 | 6 | 15368895 | ||
| Pubmed | Noncanonical role of transferrin receptor 1 is essential for intestinal homeostasis. | 2.90e-04 | 14 | 63 | 2 | 26324903 | |
| Pubmed | 2.90e-04 | 14 | 63 | 2 | 20854876 | ||
| Pubmed | Selection system for genes encoding nuclear-targeted proteins. | 2.90e-04 | 14 | 63 | 2 | 9853615 | |
| Pubmed | 3.34e-04 | 15 | 63 | 2 | 33158935 | ||
| Pubmed | 3.81e-04 | 16 | 63 | 2 | 8875997 | ||
| Pubmed | 3.81e-04 | 16 | 63 | 2 | 25942625 | ||
| Pubmed | 3.81e-04 | 16 | 63 | 2 | 36418889 | ||
| Pubmed | 4.32e-04 | 17 | 63 | 2 | 31171776 | ||
| Pubmed | Jumonji modulates polycomb activity and self-renewal versus differentiation of stem cells. | 4.85e-04 | 18 | 63 | 2 | 20064376 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 4.94e-04 | 774 | 63 | 7 | 15302935 | |
| Pubmed | mRNA expression, splicing and editing in the embryonic and adult mouse cerebral cortex. | 6.01e-04 | 20 | 63 | 2 | 23416452 | |
| Pubmed | Loss of Sip1 leads to migration defects and retention of ectodermal markers during lens development. | 6.63e-04 | 21 | 63 | 2 | 24161570 | |
| Pubmed | 7.17e-04 | 222 | 63 | 4 | 37071664 | ||
| Pubmed | 8.24e-04 | 1103 | 63 | 8 | 34189442 | ||
| Pubmed | Rap1 GTPase is required for mouse lens epithelial maintenance and morphogenesis. | 1.02e-03 | 26 | 63 | 2 | 26212757 | |
| Pubmed | TWIST1 and chromatin regulatory proteins interact to guide neural crest cell differentiation. | 1.04e-03 | 109 | 63 | 3 | 33554859 | |
| Pubmed | 1.18e-03 | 28 | 63 | 2 | 32005677 | ||
| Pubmed | Maternal DNA Methylation Regulates Early Trophoblast Development. | 1.18e-03 | 28 | 63 | 2 | 26812015 | |
| Pubmed | 1.18e-03 | 28 | 63 | 2 | 23006423 | ||
| Pubmed | 1.24e-03 | 116 | 63 | 3 | 30804394 | ||
| Pubmed | 1.45e-03 | 31 | 63 | 2 | 23312518 | ||
| Pubmed | Voltage-gated potassium channel genes are clustered in paralogous regions of the mouse genome. | 1.45e-03 | 31 | 63 | 2 | 8034307 | |
| Pubmed | 1.45e-03 | 31 | 63 | 2 | 29846670 | ||
| Pubmed | 1.55e-03 | 32 | 63 | 2 | 27806288 | ||
| Pubmed | Microphthalmia/Anophthalmia/Coloboma Spectrum – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY | 1.75e-03 | 34 | 63 | 2 | 20301552 | |
| Cytoband | 20q12-q13 | 1.85e-06 | 2 | 63 | 2 | 20q12-q13 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF20 ZNF836 ZFAT ZEB1 ZBTB39 ZNF354A ZNF670 ZNF684 ZNF592 ZNF618 ZNF780B ZNF518B ZNF841 ZFPM1 SUZ12 ZNF705B ZNF285 ZEB2 ZNF705D ZNF541 | 2.61e-16 | 718 | 47 | 20 | 28 |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 6.80e-04 | 15 | 47 | 2 | 529 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 1.35e-03 | 21 | 47 | 2 | 813 | |
| ToppCell | COVID-19_Mild-PLT_4|World / Disease Group and Platelet Clusters | 7.92e-06 | 193 | 63 | 5 | 98a52523aa1efd5d14a2878ed106828a80a33aa2 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.12e-06 | 194 | 63 | 5 | 70185c0b8e0f4e896645b17a243482ba3cdf4a5d | |
| ToppCell | COVID-19_Mild-PLT_4|COVID-19_Mild / Disease Group and Platelet Clusters | 8.97e-06 | 198 | 63 | 5 | 3d8c33dba759df0974aeb2b9a6b5167ae7a18e1f | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD8-Trm_gut_CD8|bone_marrow / Manually curated celltypes from each tissue | 6.23e-05 | 151 | 63 | 4 | 5eebdc7ad6af3cc0263e4d8c3516818305ac38f2 | |
| ToppCell | PBMC-Mild-cDC_3|Mild / Compartment, Disease Groups and Clusters | 7.42e-05 | 158 | 63 | 4 | 5fefab4831687cd8dd45f5cc84f681398069c3be | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.20e-05 | 167 | 63 | 4 | d1a13d6ada572d8ddb2da95e6e122d2b705fad7f | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Col23a1_Adamts2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.41e-05 | 168 | 63 | 4 | 3fe432267656aff81b6d92c18d1b6fc0cde73d6a | |
| ToppCell | healthy_donor-Myeloid-Monocytic-Developing_Neutrophil|healthy_donor / Disease condition, Lineage, Cell class and subclass | 9.85e-05 | 170 | 63 | 4 | cfd7f29805b7c51666b0eaf269c36c96b8765a1a | |
| ToppCell | 368C-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.01e-04 | 171 | 63 | 4 | 714a0b0d0c9886fef64170cf53eb64f0d8a47280 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_SEMA6D|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.05e-04 | 173 | 63 | 4 | 9a2d42f8d9cb834856522661d524abb91c4637c5 | |
| ToppCell | metastatic_Brain-T/NK_cells-Exhausted_Tfh|T/NK_cells / Location, Cell class and cell subclass | 1.18e-04 | 178 | 63 | 4 | 9a3581a0158dfa5a1cc942f8c532afb5e38b272a | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 180 | 63 | 4 | be10fe5bf7c3a671c42704ce7dd8226ab6896794 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 180 | 63 | 4 | 3b747a517ce75ef2ff09011c037dad7b01ed3e03 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.28e-04 | 182 | 63 | 4 | 205d9ad1ea4b7adee8054496cdde46c9c401a19a | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.28e-04 | 182 | 63 | 4 | 818b5155ec81f0059048d6070a108116ecd72e3c | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-MK-MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.34e-04 | 184 | 63 | 4 | ba65e3972b2b8d825a2c1a9d03d092cc1afad073 | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.34e-04 | 70 | 63 | 3 | 677deb7c7c100756a4cdc788d61feb45039a9a97 | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Excitatory_Neuron.Slc17a6.Rspo3_(Substantia_Innominata_(SI))|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.40e-04 | 71 | 63 | 3 | 879551882097cfaa4eccf11cb07f3bae68c777c3 | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Excitatory_Neuron.Slc17a6.Rspo3_(Substantia_Innominata_(SI))-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.40e-04 | 71 | 63 | 3 | 8557be86709925cf19125e44c909133fd5adcb62 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-04 | 187 | 63 | 4 | 48bfdb3504c3fefe5db3abac4b790c369680ab4e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-04 | 187 | 63 | 4 | 958402fcc78f4c7a7d13d659d776f3817137975f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-04 | 188 | 63 | 4 | b2d68a32314e9b099ed74d974079ad96359d1ae3 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.48e-04 | 189 | 63 | 4 | 979b7fa947538aa7ca4a219263da2575869a2caa | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-04 | 189 | 63 | 4 | fac5c291a9a87418bb0878c3d624829bdbf1f428 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.57e-04 | 192 | 63 | 4 | 8899d81306770adda893b5e146df1253971754c5 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.57e-04 | 192 | 63 | 4 | 63d1b3efe93e5ff939278ebe40bacb38218ea09b | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.57e-04 | 192 | 63 | 4 | 5fda9a465c9f77c7fa1a3ea07a2b0374bbc23b2a | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.57e-04 | 192 | 63 | 4 | 342842378c20267c5044bdd622515e8b9f895623 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.57e-04 | 192 | 63 | 4 | af453a179f3fdd4ae870f1d98a485e8c9fd726ac | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Myeloid-Monocytic-Nonclassical_Monocyte|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.57e-04 | 192 | 63 | 4 | 176b9c1dd2c91bca46e12fa5060bfe590dc18246 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Myeloid-Monocytic|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.57e-04 | 192 | 63 | 4 | 81f93b4c853f176c91b5ddef34238e37047a0e69 | |
| ToppCell | Megakaryocytic-erythropoietic-Megakaryo-cells-Megakaryocyte|World / Lineage, cell class and subclass | 1.60e-04 | 193 | 63 | 4 | 352cd442b6e62f09b6d22a139774067873644594 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 1.60e-04 | 193 | 63 | 4 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.64e-04 | 194 | 63 | 4 | 68d15917ae222cba0ad9e716d29eebb6c5f00f69 | |
| ToppCell | mild_COVID-19_(asymptomatic)-B_naive|World / disease group, cell group and cell class (v2) | 1.67e-04 | 195 | 63 | 4 | e763d9a431052c03cc6d514f2736506c6667e2be | |
| ToppCell | control-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.77e-04 | 198 | 63 | 4 | 35499a5231818e3432cf69b5c4a58c02f7771db8 | |
| ToppCell | Sepsis-Bac-SEP-Lymphocyte-T/NK-MAIT|Bac-SEP / Disease, condition lineage and cell class | 1.77e-04 | 198 | 63 | 4 | aea3654b16785aa9857ed646bd0d0dc9724df364 | |
| ToppCell | BAL-Mild-Myeloid|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.80e-04 | 199 | 63 | 4 | 0f0fcc6fb980167cfa9aa404b845441fb95a08f4 | |
| ToppCell | BAL-Mild-Myeloid|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.80e-04 | 199 | 63 | 4 | 3662ed5d929ab64293e65f33dabcefc3458a08e5 | |
| ToppCell | Mild_COVID-19-Myeloid|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.80e-04 | 199 | 63 | 4 | c0a9f5629db5beff7c07c9d111a7707e062d746f | |
| ToppCell | Mild-Myeloid|Mild / Condition, Lineage, Cell class and cell subclass | 1.80e-04 | 199 | 63 | 4 | 0678e50ffda664fb76681a1ee9021deab73bf850 | |
| ToppCell | control-HLA-DR+_CD83+_Monocyte|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.80e-04 | 199 | 63 | 4 | f1b370d2869ad29c9d8ff41fdcc486fffa781ee2 | |
| ToppCell | Mild-Myeloid-Macrophages-FCN1+SPP1+|Mild / Condition, Lineage, Cell class and cell subclass | 1.80e-04 | 199 | 63 | 4 | 2cbaef86af870a228cb46895dd765ea8894c83c5 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macro_CHIT1|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.80e-04 | 199 | 63 | 4 | 368e2bafae00ce8e9c6ea480f81b78f96b680acd | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.84e-04 | 200 | 63 | 4 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.84e-04 | 200 | 63 | 4 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | COVID-19-Myeloid|COVID-19 / Condition, Lineage and Cell class | 1.84e-04 | 200 | 63 | 4 | 4c9e936b5e100c1a3ef10ea262febccf8226df9f | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.84e-04 | 200 | 63 | 4 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer|World / Primary Cells by Cluster | 1.84e-04 | 200 | 63 | 4 | db10f76938af553d1a2275bb02ef75dff3c3135b | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.84e-04 | 200 | 63 | 4 | 8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer-21|World / Primary Cells by Cluster | 1.84e-04 | 200 | 63 | 4 | 30a3e4aee12ec1b5acdce90f86c9733c27a7f6fc | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.84e-04 | 200 | 63 | 4 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.84e-04 | 200 | 63 | 4 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Neuronal-GABAergic_neurons|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.84e-04 | 200 | 63 | 4 | c6bbd33bca86ac7a76a7ba704b3e141237d04549 | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.84e-04 | 200 | 63 | 4 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| Disease | factor VII activating protease measurement | 4.25e-06 | 55 | 58 | 4 | EFO_0009368 | |
| Disease | Cognitive impairment | 2.06e-04 | 11 | 58 | 2 | HP_0100543 | |
| Disease | rheumatic heart disease (biomarker_via_orthology) | 2.47e-04 | 12 | 58 | 2 | DOID:0050827 (biomarker_via_orthology) | |
| Disease | bone mineral accretion measurement, response to corticosteroid | 3.40e-04 | 14 | 58 | 2 | EFO_0007591, GO_0031960 | |
| Disease | Left ventricular mass to end-diastolic volume ratio | 1.11e-03 | 25 | 58 | 2 | EFO_0010556 | |
| Disease | colorectal cancer (is_implicated_in) | 1.76e-03 | 121 | 58 | 3 | DOID:9256 (is_implicated_in) | |
| Disease | generalised epilepsy | 4.73e-03 | 52 | 58 | 2 | EFO_0005917 | |
| Disease | Leukemia, Myelocytic, Acute | 4.82e-03 | 173 | 58 | 3 | C0023467 | |
| Disease | systemic scleroderma (is_marker_for) | 4.91e-03 | 53 | 58 | 2 | DOID:418 (is_marker_for) | |
| Disease | pulse pressure measurement | 5.65e-03 | 1392 | 58 | 8 | EFO_0005763 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HLRYHGSSYSRCFLE | 51 | Q14236 | |
| LQHRSHYFEGVLKCY | 266 | P54619 | |
| TNYSQEKHRCEYLHS | 586 | P55199 | |
| VSSRHHQTCTLDYSY | 461 | O94812 | |
| FSPECSKHFHRLYYN | 86 | Q6UXT8 | |
| SKHFHRLYYNTRECS | 91 | Q6UXT8 | |
| LRTTNECHKTYYTRH | 11 | Q8N8R7 | |
| FTHYRCSNHVYYAKR | 106 | Q8NEB7 | |
| TFRDYLHYHIKCSKA | 246 | O15144 | |
| HNSIYEQSCEAYKHR | 586 | Q9C0A0 | |
| HEFYNFSREYLTHSK | 111 | Q3LIE5 | |
| HLRAYHRCLYYTRFQ | 61 | Q9H2A7 | |
| HYDDHRKSALYFAVS | 351 | A6NK59 | |
| ADTYSEFHKHYARIS | 351 | Q6W2J9 | |
| YNHSKMCDSHYLESR | 46 | P49759 | |
| IKRYVHQNFSSHYRA | 26 | P57729 | |
| YNCYHEGKSFQLRHR | 31 | Q9H2L5 | |
| ASDHDYRTQYHKFTA | 1376 | Q86VF7 | |
| HCYVRIKDSGLRFHY | 71 | Q8IUS5 | |
| FHDLSKRYYNTFHCN | 2541 | Q2LD37 | |
| QTYGSCRKQRHYASH | 471 | P83111 | |
| KHYPSQYHERQCRSS | 326 | Q6ZUT3 | |
| ETYTVHKRYYCASRH | 696 | Q8IX07 | |
| KDCPRNHSHTRNFYY | 226 | Q8IZP7 | |
| HCIDFHYYFSSRDRS | 101 | O14522 | |
| YSSCKYSHLITSHQF | 371 | O43825 | |
| IKLSRHSYFSSYQDH | 291 | Q8WZ79 | |
| LYYLSHDGRRFHRAC | 246 | Q9HCS2 | |
| CTSTIPFHYKRYTHF | 161 | Q6PJP8 | |
| LKFHYHTLRLYSAVC | 1651 | Q92736 | |
| VAEKHRGNYTCHASY | 186 | P14778 | |
| TICYHYFRGHNESKA | 426 | Q15262 | |
| AYYSKHADGLCHRLT | 231 | P12931 | |
| HSELKHTNYCFLTLY | 641 | Q4G0N8 | |
| EQNYCESRYHFLHSA | 156 | Q7L5D6 | |
| CHLRNDSHYVVYTRE | 571 | Q07837 | |
| HYKYHTFLRCRDQTL | 1976 | Q9ULL5 | |
| ESSYYRHHFARQDLT | 601 | Q15437 | |
| FYKNHRAYTRALHSF | 906 | Q0P6D6 | |
| ARRFYQYAHEHTACT | 551 | Q86XI2 | |
| RYSSSLYKHSRFHTG | 281 | Q5T5D7 | |
| VRTHTREHLYYCSQC | 761 | Q9P243 | |
| KAFISNYIRYHERTH | 486 | P17024 | |
| YKYYNCFQTHVRAHR | 156 | Q5T7W0 | |
| HLKLCHSRFIFNYVY | 466 | Q15022 | |
| YFQTHVKENCLHYAR | 781 | Q92610 | |
| EKGHYAYDCHRYSRR | 111 | Q16629 | |
| HDYRVYCNLSAAHTF | 1171 | Q92626 | |
| YTRHHSLKFASCGSY | 371 | A0A1W2PR48 | |
| CHKVYFTHRTDYNSL | 326 | Q9H0V1 | |
| ECRKTFRYHYQLTEH | 701 | Q9Y6R6 | |
| SFKSEAAYRYHVSQH | 546 | O15060 | |
| SQHMNHRYSYCKREA | 976 | P37275 | |
| VFTYYSCLARHQRMH | 461 | Q6ZN19 | |
| YTNCFYLRRHKMTHT | 181 | P0CI00 | |
| YTNCFYLRRHKMTHT | 181 | P0CH99 | |
| FKCHRTYRLFAVVYH | 726 | Q14694 | |
| YKHLRTHTVEKSYRC | 286 | O60765 | |
| SQHMNHRYSYCKREA | 1071 | O60315 | |
| CYNNSHRDKALHFYT | 11 | Q96EK4 | |
| KCFSYSSYFHLHQRD | 491 | Q96NJ3 | |
| VFSYYSCLARHRKIH | 646 | Q6ZNA1 | |
| HCDKAFNYSSYLREH | 201 | Q9BS34 | |
| FNYSSYLREHERTHT | 206 | Q9BS34 | |
| SYCDYRSLRRHYEVH | 206 | Q9H0D2 | |
| HCSYISYTKGEFQRH | 166 | Q9C0D4 |